Mohamad Mohty

Hematology Dpt, CHU de Nantes, France

Any competing interests declared are displayed with individual evaluations.

Faculty Member: Hematology > Leukemia & Proliferative Disorders of Hematic Cells (since 20 September 2007)

All recent recommendations

• 3.0
  Fludarabine/i.v. BU conditioning regimen: myeloablative, reduced intensity or both?
  Recommended by Mohamad Mohty